Back to STATE STREET CORP STATE STREET CORP

CTNMCTNM
9 quarters

Position history for STATE STREET CORPSTATE STREET CORP's holdings in CONTINEUM THERAPEUTICS INC

STATE STREET CORP holds 425,902 shares of CTNM (CONTINEUM THERAPEUTICS INC), worth $7M as of 2026-Q2. The position was increased (+320.5% shares). CTNM represents 0.0% of STATE STREET CORP's portfolio.

Current Value

$7M

Current Shares

425,902

Total Value Change

+$5.4M

Total Shares Change

+334,096

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
425,902
+320.5%
$7M0.0%$16.39
44
2026-Q1
Increased
101,278
+20.0%
$1.3M0.0%$14.10
21
2025-Q4
Increased
84,428
+35.2%
$965,0120.0%$11.40
22
2025-Q3
Increased
62,428
+116.0%
$733,5290.0%$11.82
27
2025-Q2
Decreased
28,900
-77.2%
$114,7330.0%$4.11
0
2025-Q1
Increased
126,864
+1.7%
$885,5110.0%$7.07
17
2024-Q4
Increased
124,744
+9.8%
$1.8M0.0%$14.47
28
2024-Q3
Increased
113,566
+23.7%
$2.2M0.0%$18.84
32
2024-Q2
New
91,806
-
$1.6M0.0%$17.61
35

Other major holders of CTNM: Janus Henderson Group Ltd., BlackRock, Inc., FRANKLIN RESOURCES INC, BALYASNY ASSET MANAGEMENT L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used